Comprehensive genomic profiling from
a blood sample. Fast.
For patients with advanced solid tumour cancers
Before 1st Line Treatment
Get ahead of the challenges of tissue testing in advanced NSCLC by utilizing Guardant360® to guide 1st line treatment decisions
Get genomic information on over 70+ genes, including MSI across multiple solid tumors to help find cancer therapies and clinical trials.